B2M and cancer: For example, MHC class I-B2M expression protects cancer cells from phagocytosis via engagement of LILRB1/LILRB2 expressed in immunosuppression-related cells, such as tolerogenic dendritic cells (DCs) and M2-type macrophages (22–24).